The I.M. Rosenzweig Junior Investigator Award Winners​

The I.M. Rosenzweig Junior Investigator Award was established to encourage researchers to maintain and enhance their interest in PF research during the early stages of their academic career. 

The Albert Rose Established Investigator Award Winners

Created to allow established investigators to explore novel, innovative areas of research, the Albert Rose Established Investigator Award provides critical support to the development of new projects, and enables the investigator to pursue additional funding through the National Institutes of Health or other agencies. Two $50,000 grants are awarded per annual cycle, disbursed over a two-year period.

Jung-Whan (Jay) Kim, DVM, PhD

Apr 19, 2021, 16:27 PM
Title : Jung-Whan (Jay) Kim, DVM, PhD
First Name : Jung-Whan (Jay)
Middle Name :
Last Name : Kim, DVM, PhD
Position :
University : University of Texas at Dallas
Proposal Title : "Evaluation of Hypoxia-inducible Factor-1 (HIF-1) Signaling as Anti-fibrosis Therapy"
Proposal Funder :
Dr. Jung-whan Kim is an Assistant Professor of Molecular and Cell Biology at the University of Texas at Dallas.

He received his DVM degree at Konkuk University, Seoul, Korea and completed his PhD as a Howard Hughes Medical Institute (HHMI) pre-doctoral scholar at Johns Hopkins School of Medicine. Since he joined the University of Texas at Dallas as a tenure-track Assistant Professor in 2013, his research has focused on the mechanisms underlying the effects of hypoxic responses in the pulmonary fibrosis and tumorigenesis.

Among many cell populations involved in the disease progression of pulmonary fibrosis, his group is interested in fibroblasts, a type of cell providing structural support for various tissues, are responsible for scarring tissues by producing the extracellular matrix such as collagen in response to tissue damage and inflammation. Utilizing various transgenic animal models, his group seeks to better understand how fibroblasts contribute to the development of fibrosis, which can be exploited for a novel therapeutic strategy.